MIFH
GSK icon

Migdal Insurance & Financial Holdings’s GSK GSK Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-443
Closed -$24K – 643
2021
Q4 		$24K Sell
443
-979
-69% -$50.9K ﹤0.01% 538
2021
Q3 		$68K Buy
+1,422
New +$71.4K ﹤0.01% 407

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Migdal Insurance & Financial Holdings's GSK Position: Q1 2022 in Review

Migdal Insurance & Financial Holdings sold out of GSK (GSK) in Q1 2022, closing a stake of 443 shares — an estimated $24K sold.

Migdal Insurance & Financial Holdings first reported a position in GSK in Q3 2021 and held it in 2 quarters. The position peaked at $68K in Q3 2021. 930 funds tracked by Wall St. Rank hold GSK as of Q1 2022.

  • Migdal Insurance & Financial Holdings reported no remaining GSK position as of Q1 2022 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 443 GSK shares in Q1 2022, an estimated $24K.
  • Migdal Insurance & Financial Holdings first reported a position in GSK in Q3 2021 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's GSK position peaked at $68K in Q3 2021.
  • 930 funds tracked by Wall St. Rank held GSK as of Q1 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2022, filed 2 May 2022.